| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 05/25/2005 | EP1532105A1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| 05/25/2005 | EP1531807A1 Bazedoxifene treatment regimens |
| 05/25/2005 | EP1442016A4 1h-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 05/25/2005 | EP1259231B1 Naphthoquinone derivatives as cd45 inhibitors |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2005 | EP1039911B1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA 2 INHIBITORS |
| 05/25/2005 | DE10347383A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors |
| 05/25/2005 | CN1620429A Derivatives of alpha-phenylthiocarboxylic and g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPAR alpha activation |
| 05/25/2005 | CN1620313A Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression |
| 05/24/2005 | US6897276 Coordination polymerization catalyst for alpha-olefins |
| 05/24/2005 | US6897240 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use |
| 05/24/2005 | US6897237 MMP-12 inhibitors |
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/24/2005 | CA2174000C Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane |
| 05/21/2005 | CA2486838A1 Organic amine salts of glutamic acid derivatives and their application |
| 05/19/2005 | WO2005044923A1 Cyanine dye labelling reagents |
| 05/19/2005 | WO2005044796A1 2-halogen-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives |
| 05/19/2005 | WO2005044261A1 Melatonin analogue prodrugs |
| 05/19/2005 | WO2005044260A1 Use of crth2 antagonist compounds in therapy |
| 05/19/2005 | WO2005028436A3 Thalidomide analogs as tnf-alpha modulators |
| 05/19/2005 | WO2005016868A3 Matrix metalloproteinase inhibitors |
| 05/19/2005 | WO2004041780A3 N-(indole-2-carbonyl) amides as anti-diabetic agents |
| 05/19/2005 | US20050107618 Processes for the preparation of N-substituted phthalimides |
| 05/19/2005 | US20050107543 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 05/19/2005 | US20050107463 Novel prostamides for the treatment of glaucoma and related diseases |
| 05/19/2005 | US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors |
| 05/19/2005 | US20050107445 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 05/19/2005 | US20050107362 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
| 05/19/2005 | US20050107321 FLK-1 is a receptor for vascular endothelial growth factor |
| 05/19/2005 | US20050107258 Auxinic analogues of indole-3-acetic acid |
| 05/19/2005 | US20050106709 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
| 05/19/2005 | US20050106106 In-vivo diagnostic method by near infrared radiation |
| 05/19/2005 | DE10347386A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors |
| 05/19/2005 | DE10346939A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases |
| 05/19/2005 | CA2544752A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 05/19/2005 | CA2544548A1 2-halogen-6-alkyl-phenyl-substituted tetramic acid derivatives |
| 05/19/2005 | CA2544537A1 2-halogen-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives |
| 05/19/2005 | CA2543199A1 Use of crth2 antagonist compounds in therapy |
| 05/18/2005 | EP1530572A2 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
| 05/18/2005 | EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 05/18/2005 | EP1317430B1 (2-azabicyclo [2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | EP1176139B1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors |
| 05/18/2005 | EP0946173B1 Preparation of 3-fluoro oxindole derivatives |
| 05/18/2005 | CN1617865A Phenylalkynes |
| 05/18/2005 | CN1617860A [1.2]-oxazin-3, 5-diones |
| 05/18/2005 | CN1617855A Inhibitors of cytosolic phospholipase A2 |
| 05/18/2005 | CN1617854A Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 05/18/2005 | CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity |
| 05/18/2005 | CN1616455A Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate |
| 05/18/2005 | CN1616428A Acenaphthene heterocyclic compound and its cell fading inducing and anti-tumor use |
| 05/18/2005 | CN1616427A New method for preparing medicine mitiglinide for treating diabetes |
| 05/18/2005 | CN1616426A Indolyl styrene salt compound, high density recording medium including said compound and its preparing method |
| 05/18/2005 | CN1616425A Noval benzoindoline compounds, their preparing method and pharmaceutical composition containing them |
| 05/18/2005 | CN1616386A Intermediate for preparing isothiazole derivatives |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/18/2005 | CN1202052C Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system |
| 05/18/2005 | CN1201735C Mycobacterial inhibitors |
| 05/17/2005 | US6894185 Substituted chiral allosteric hemoglobin modifiers |
| 05/17/2005 | US6894174 Water-soluble polyimides and methods of making and using same |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/17/2005 | US6894070 Herbicides |
| 05/17/2005 | US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides |
| 05/17/2005 | US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine |
| 05/17/2005 | CA2347757C Method for producing (+)-exo-6-phenyl-3-azabicyclo-[3.2.0]heptanes |
| 05/17/2005 | CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 05/12/2005 | WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 05/12/2005 | WO2005042497A2 Benzimidazoles useful as modulators of ion channels |
| 05/12/2005 | WO2005042469A1 Aromatic amino acid labeled with stable isotope, method for incorporating the same into target protein and method for analyzing protein structure using nmr |
| 05/12/2005 | WO2005041954A1 Indirubin-type compounds, compositions, and methods for their use |
| 05/12/2005 | WO2005019169A3 Indoline derivatives as ppar-delta modulators |
| 05/12/2005 | WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof |
| 05/12/2005 | WO2005000803A8 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst |
| 05/12/2005 | WO2004096802A3 ANTIBIOTIC TETRAHYDRO-β-CARBOLINE DERIVATIVES |
| 05/12/2005 | WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 05/12/2005 | US20050101788 Method for manufacture of sertindole |
| 05/12/2005 | US20050101786 N-alkylation of indole derivatives |
| 05/12/2005 | US20050101781 Eponemycin and epoxomicin analogs and uses thereof |
| 05/12/2005 | US20050101763 For use as building blocks in photolithographic solid-phase peptide synthesis; microarrays |
| 05/12/2005 | US20050101661 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents |
| 05/12/2005 | US20050101654 Process for the preparation of N-amino substituted heterocyclic compounds |
| 05/12/2005 | US20050101623 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors |
| 05/12/2005 | US20050101596 Such as N,N-dimethyl-3-(phenylsulfonyl)-6,7,8,9-tetrahydro-3H-benzo[e]indol-8-amine; for treatment of central nervous system disorders related to or affected by serotonin receptor antagonists such as neurodegenerative disorders, attention deficit disorder, obsessive compulsive disorder, and drug abuse |
| 05/12/2005 | US20050101584 Selective estrogen receptor-beta ligands |
| 05/12/2005 | US20050101004 Screening for a compound to inhibit the urge for urinary incontinence by detecting activation of KCNQ protein in the host cell; measuring the membrane potential of the host cell and selecting the compound whose presence causes hyperpolarization in themembrane potential of the host cell |
| 05/12/2005 | US20050100902 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors |
| 05/12/2005 | CA2543942A1 Indirubin-type compounds, compositions, and methods for their use |
| 05/12/2005 | CA2543918A1 Benzimidazoles useful as modulators of ion channels |
| 05/12/2005 | CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 05/11/2005 | EP1530097A2 Organophotoreceptor with charge transport material having a vinyl ether group |
| 05/11/2005 | EP1530096A2 Organophotoreceptor with a hydrazone polymer charge transport material |
| 05/11/2005 | EP1530094A2 Organophotoreceptor with charge transport material having three arylamino groups |
| 05/11/2005 | EP1529776A2 Amino acid derivatives and sweetening agent |
| 05/11/2005 | EP1529034A1 Benzoylpyrazolones substituted by 3-aminocarbonyl |
| 05/11/2005 | EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 05/11/2005 | EP1528923A1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
| 05/11/2005 | EP1528919A2 Therapeutic use of aryl amino acid derivatives |
| 05/11/2005 | EP1421064B1 Process for the preparation of 3-spiro'cyclohexam-1,3'-'3h!indolin-2'-one! derivatives |
| 05/11/2005 | CN1615311A 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 05/11/2005 | CN1615305A Coumarin derivatives, process for their production and use thereof |